Study suggests hypercalcemia relapse is rare after dog parathyroidectomy: full analysis

A new American Journal of Veterinary Research study suggests that persistent and recurrent hypercalcemia are uncommon in dogs undergoing surgery for primary hyperparathyroidism, reinforcing parathyroidectomy’s role as a highly effective definitive treatment. The retrospective review covered cases from three academic veterinary hospitals over a 10-year period, from 2012 through 2022, and examined dogs treated surgically for autonomously functioning parathyroid tissue. The paper’s stated aim was not just to measure how often hypercalcemia persists or returns, but also to examine the causes behind those cases and clarify the definitions used to describe them. (merckvetmanual.com)

That question matters because canine primary hyperparathyroidism is uncommon, and much of the published literature has focused either on diagnosis or on short-term postoperative hypocalcemia rather than long-term surgical failure. Standard references describe surgery or ablation as the main definitive options for dogs with primary hyperparathyroidism. Older studies have also suggested that recurrence after apparently curative treatment is unusual, although not impossible, especially in dogs with multigland disease or atypical pathology. (merckvetmanual.com)

The new AJVR paper builds on that background by reviewing medical records for signalment, presenting signs, diagnostics, treatment, histopathology, and outcomes. Based on the abstract summary provided, the authors categorized dogs by follow-up status to identify cases of persistent and recurrent hypercalcemia after surgery. While the full article text was not readily accessible in search results, the study’s framing suggests it is addressing a practical gap for clinicians: not every postoperative calcium abnormality means the same thing, and inconsistent definitions can make outcomes harder to compare across hospitals and publications. (merckvetmanual.com)

Existing literature gives some context for what those failures may look like when they do occur. Historical veterinary reports have linked persistent hypercalcemia to parathyroid hyperplasia involving more than one gland, while isolated case reports describe recurrence from metastatic parathyroid adenocarcinoma or residual ectopic tissue. In contrast, more contemporary work has focused heavily on predicting and managing postoperative hypocalcemia, including a 2012 JAVMA report in 17 dogs that found hypocalcemia after parathyroidectomy in 12 cases. More recently, a 2026 PubMed-indexed study on outpatient management after parathyroidectomy again centered on hypocalcemia and calcium supplementation, underscoring where most of the day-to-day postoperative attention still falls. (pubmed.ncbi.nlm.nih.gov)

Direct expert reaction to this specific AJVR paper was not easy to locate in open web results. Still, specialty and educational sources are broadly aligned on the clinical message: surgery is usually successful, but patients need structured postoperative calcium monitoring, and persistent hypercalcemia should prompt consideration of missed tissue, multigland disease, or less common pathology. Angell’s surgical review, for example, notes that surgery remains the best definitive treatment for most dogs, while also acknowledging a possible role for cinacalcet in rare nonsurgical or refractory cases. (mspca.org)

Why it matters: For veterinarians, this study may be most useful as a benchmarking paper. If persistent and recurrent hypercalcemia truly are uncommon across multiple academic centers, that gives internists and surgeons stronger footing when counseling pet parents about prognosis after parathyroidectomy. It also shifts the follow-up conversation: clinicians still need to monitor closely for postoperative hypocalcemia in the near term, but long-term recurrence may deserve a more targeted workup rather than being treated as an expected risk. In referral practice, clearer definitions could also improve how cases are triaged for repeat imaging, repeat surgery, or medical therapy. (pubmed.ncbi.nlm.nih.gov)

There’s also a practice-management angle. Primary hyperparathyroidism can present subtly, often with polyuria, polydipsia, lethargy, weakness, or calcium-containing urolithiasis, and it may be found incidentally on chemistry panels. Because the condition is uncommon, many general practitioners and emergency teams may only see a handful of cases. Better data on true persistence and recurrence rates can help standardize discharge plans, recheck intervals, and thresholds for concern when calcium values drift after surgery. (merckvetmanual.com)

What to watch: The next thing to watch is whether the full AJVR publication, conference discussion, or institutional summaries provide the study’s exact numbers, definitions, and pathology breakdown. Those details will determine how actionable the findings become, especially for deciding which dogs need longer surveillance for recurrent disease and which postoperative calcium changes are most likely to resolve without further intervention. (ovid.com)